Immunization

In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.

The acceptance will lead to vaccines that provide better protection against the KP.2 strain of SARS-CoV-2.

Individuals with chronic conditions like asthma, diabetes, and chronic obstructive pulmonary disease face an increased risk of developing RSV.

Patient fears can be mitigated by pharmacists who use targeted communication strategies to bolster acceptance.

The mRNA-1345 vaccine provides a one-off mechanism of protection because of its single-dose prefilled syringes

The findings indicate that zoster vaccine recombinant reduced dementia risk by 17% in an analysis of over 200,000 patients.

Immunization rates have not returned to pre-pandemic levels, leaving millions of children and infants at risk for measles or diphtheria, tetanus, and pertussis.

Educate patients about the importance of vaccination in preventing severe disease.

Providing immunization coadministration and assisting with insurance coverage are strategies to improve access.

Understanding preventive care reduces the risk of illnesses and decreases future costs.

Differentiating between the 3 available options can help identify which is best for individual patients.

Proper timing and vaccine selection are crucial for optimal immune responses.

With new guidance coming for the 2024-2025 season, pharmacists must stay up to date with current vaccine recommendations.

A strong recommendation from trusted health care professionals can make a difference.

Pharmacists have become the driving force behind immunizations in the US.

Investigators found that the risk of long COVID decreased over the course of the pandemic.

Many ways exist to best serve communities and the bottom line beyond vaccine ordering and increased staffing.

Pharmacists’ awareness of respiratory syncytial virus and their role in educating about the vaccine have grown dramatically.

RSVpreF is currently the only FDA-approved RSV vaccine for pregnant individuals.

The ACIP recommendations are designed to improve access to RSV vaccination, emphasizing the need to get vaccinated.

The committee, after being presented evidence by the working group, recommended the vaccine for adults aged 65 and older and those 19 or older who have current recommendations to receive a pneumococcal vaccine.

Staying updated on travel vaccines and applying sunscreen are examples of summer health counseling tips

Pharmacies can position themselves as leaders in immunization services.

V116 (Capvaxive; Merck) elicited higher immune responses than the comparator for the serotypes that are unique to the vaccine, according to studies submitted to the FDA.

The SCDM model demands more than the traditional roles assigned to pharmacists, requiring an enhanced level of patient engagement, medical knowledge, and legal authority to implement effectively

The expanded indication is for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in adults aged 50 through 59 years who are at an increased risk.

Serotypes associated with V116 (Merck & Co. Inc.) had higher clinical and economic burden for individuals with invasive pneumococcal disease.

A single dose of the vaccine showed long-lasting protection against RSV-associated lower respiratory tract disease in older adults.